Methoxetamine

Methoxetamine
Clinical data
Other namesMXE; 3-MeO-2'-oxo-PCE
Addiction
liability
High
Drug classNMDA receptor antagonist; Dissociative hallucinogen; General anesthetic
ATC code
  • None
Legal status
Legal status
Pharmacokinetic data
Elimination half-life3–6 hours
Identifiers
  • (R/S)-2-(3-Methoxyphenyl)-2-(ethylamino)cyclohexanone
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC15H21NO2
Molar mass247.338 g·mol−1
3D model (JSmol)
  • O=C1CCCCC1(C2=CC=CC(OC)=C2)NCC
  • InChI=1S/C15H21NO2/c1-3-16-15(10-5-4-9-14(15)17)12-7-6-8-13(11-12)18-2/h6-8,11,16H,3-5,9-10H2,1-2H3 Y
  • Key:LPKTWLVEGBNOOX-UHFFFAOYSA-N Y
 NY (what is this?)  (verify)

Methoxetamine (MXE) is a dissociative hallucinogen that has been sold as a designer drug. It differs from many dissociatives such as ketamine and phencyclidine (PCP) that were developed as pharmaceutical drugs for use as general anesthetics in that it was designed specifically to increase the antidepressant effects of ketamine.

MXE is an arylcyclohexylamine. It acts mainly as an NMDA receptor antagonist, similarly to other arylcyclohexylamines like ketamine and PCP.